These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Epstein-Barr virus-associated lymphoproliferative syndromes: studies in two European families. Schuster V; Dohrmann E; Kreth HW Cancer Detect Prev; 1991; 15(1):65-7. PubMed ID: 1646073 [TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus as an etiological agent in the pathogenesis of lymphoproliferative and aproliferative diseases in immune deficient patients. Purtilo DT; Tatsumi E; Manolov G; Manolova Y; Harada S; Lipscomb H; Krueger G Int Rev Exp Pathol; 1985; 27():113-83. PubMed ID: 3017882 [No Abstract] [Full Text] [Related]
10. Epstein-Barr virus-induced diseases in boys with the X-linked lymphoproliferative syndrome (XLP): update on studies of the registry. Purtilo DT; Sakamoto K; Barnabei V; Seeley J; Bechtold T; Rogers G; Yetz J; Harada S Am J Med; 1982 Jul; 73(1):49-56. PubMed ID: 6283885 [TBL] [Abstract][Full Text] [Related]
11. Malignant B-cell lymphoma following and associated with infectious mononucleosis. A comparison of two cases. Pattengale PK; Taylor CR; Pegalow C Am J Pediatr Hematol Oncol; 1981; 3(1):35-42. PubMed ID: 6263125 [TBL] [Abstract][Full Text] [Related]
12. Antibody responses to Epstein-Barr virus in families with the X-linked lymphoproliferative syndrome. Sakamoto K; Freed HJ; Purtilo DT J Immunol; 1980 Aug; 125(2):921-5. PubMed ID: 6248598 [No Abstract] [Full Text] [Related]
13. Immunoglobulin class and subclass deficiencies prior to Epstein-Barr virus infection in males with X-linked lymphoproliferative disease. Grierson HL; Skare J; Hawk J; Pauza M; Purtilo DT Am J Med Genet; 1991 Sep; 40(3):294-7. PubMed ID: 1683154 [TBL] [Abstract][Full Text] [Related]
14. Immunodeficiency as a factor in lymphomagenesis. Purtilo DT; Sakamoto K Perspect Pediatr Pathol; 1984; 8(2):181-91. PubMed ID: 6330665 [TBL] [Abstract][Full Text] [Related]
15. Documentation of Epstein-Barr virus infection in immunodeficient patients with life-threatening lymphoproliferative diseases by Epstein-Barr virus complementary RNA/DNA and viral DNA/DNA hybridization. Saemundsen AK; Purtilo DT; Sakamoto K; Sullivan JL; Synnerholm AC; Hanto D; Simmons R; Anvret M; Collins R; Klein G Cancer Res; 1981 Nov; 41(11 Pt 1):4237-42. PubMed ID: 6272968 [TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus infections in the X-linked recessive lymphoproliferative syndrome. Purtilo DT; Szymanski I; Bhawan J; Yang JP; Hutt LM; Boto W; DeNicola L; Maier R; Thorley-Lawson D Lancet; 1978 Apr; 1(8068):798-801. PubMed ID: 85816 [TBL] [Abstract][Full Text] [Related]
17. Prevention and treatment of Epstein-Barr virus (EBV)-associated lymphoproliferative diseases in immune deficient patients. Purtilo DT AIDS Res; 1986 Dec; 2 Suppl 1():S177-81. PubMed ID: 2435295 [TBL] [Abstract][Full Text] [Related]
19. [Studies on Epstein-Barr virus (EBV) infection and reactivity of peripheral B lymphocytes to EBV in patients with ataxia telangiectasia]. Okano M Hokkaido Igaku Zasshi; 1986 Jul; 61(4):584-92. PubMed ID: 3019855 [TBL] [Abstract][Full Text] [Related]
20. X-linked lymphoproliferative syndrome. Natural history of the immunodeficiency. Sullivan JL; Byron KS; Brewster FE; Baker SM; Ochs HD J Clin Invest; 1983 Jun; 71(6):1765-78. PubMed ID: 6306053 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]